4
Changes in Ownership
REPLIGEN CORP Filed Acc 0000899243-22-028506
Senior VP, R&D sold 4,840 shares at an average $254.32 ($1,230,886)
- Senior VP, R&D acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Option exercise | +2,000 | $33.05 | $66,100 | 22,110 | D |
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Option exercise | +1,354 | $59.52 | $80,590 | 23,464 | D |
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Option exercise | +646 | $86.10 | $55,621 | 24,110 | D |
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Sale | −800 | $255.20 | $204,160 | 23,310 | D |
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Sale | −4,040 | $254.14 | $1,026,726 | 19,270 | D |
| Derivatives | |||||||
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Option exercise · Stock Option (Right to Buy) | +2,000 | 0 | D | ||
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Option exercise · Stock Option (Right to Buy) | +1,354 | 0 | D | ||
| KURIYEL RALF Senior VP, R&D | 2022-08-11 | Option exercise · Stock Option (Right to Buy) | +646 | 400 | D | ||
| Open-market sales · 4,840 sh · avg $254.32 · $1,230,886 | |||||||
Loading xslF345X03/doc4.xml…